Volumetric PET biomarkers may help predict risk of toxicity from CAR T-cell therapy in patients with large B-cell lymphoma, ...

CAR T-cell therapy is starting to enter the treatment conversations sooner with patients with multiple myeloma, according to ...

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated ...

Panelists discuss how both amivantamab plus lazertinib and osimertinib-based regimens show good central nervous system (CNS) ...

Panelists discuss how the MARIPOSA study findings demonstrated significant progression-free survival and overall survival ...

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, ...

Q&A: Prioritizing QOL Important to Treating HR+, HER2- Metastatic Breast Cancer ...

This program focused on patient perspectives and shared decision-making in the context of multiple myeloma, bringing together a panel that included a nurse practitioner, a patient living with the ...

The discussion focused on the diagnostic process for multiple myeloma, emphasizing the importance of comprehensive evaluation through various clinical tools. Diagnosing this complex disease requires ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

Formal communication could help ease the transition of care from specialized myeloma centers to community clinic, according ...

Patient Perspectives and Shared Decision-Making in Multiple MyelomaJune 27th 2025 ...